55PEfficacy and safety of nintedanib and docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): First interim results of the ongoing non-interventional study VARGADO (NCT02392455). (17th December 2018) - Grohe, C; Gleiber, W; Haas, S; Mueller-Huesmann, H; Schulze, M; Atz, J; Kaiser, R